Relationship between symptom burden and health status: analysis of the MDASI-BT and EQ-5D

Neuro-oncology Practice
Elizabeth VeraTerri Armstrong

Abstract

Patients with glioma are highly symptomatic and often have functional limitations from the time of diagnosis. Measuring health status may have value in determining impact of disease. This study provided a description of health status and utility scores in glioma patients throughout the illness trajectory using the EQ-5D (a functional measure of general health status). Furthermore, it evaluated the information provided by the MD Anderson Symptom Inventory-Brain Tumor (MDASI-BT; a measure of symptom burden and interference) in describing health-related quality of life as assessed by the EQ-5D. Glioma patients completed the EQ-5D and MDASI-BT. Disease and clinical details were collected by medical record review. Linear regression evaluated whether MDASI-BT scores adequately predict patient health outcomes measured by the EQ-5D. The sample included 100 patients (65% male, 78% with a glioblastoma, median age 52 [range, 20-75], 56% in active treatment). Seventy-two percent of patients reported functional limitations in at least 1 area. Extreme cases reported inability to perform usual activities (8%) and significant anxiety/depression (5%). The MDASI-BT neurologic factor and activity-related interference (walking/activity/work) expla...Continue Reading

References

Dec 1, 1993·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D A Revicki, R M Kaplan
Jun 27, 2000·Social Science & Medicine·P SalanderR Henriksson
Apr 7, 2006·Journal of Neuro-oncology·T S ArmstrongC Cleeland
Jun 22, 2007·Journal of Neuro-oncology·Sarah BradleyCatherine Bender
Dec 25, 2007·Health and Quality of Life Outcomes·A Simon PickardDavid Cella
Jul 19, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lynda McKenzie, Marjon van der Pol
Apr 2, 2009·Health and Quality of Life Outcomes·Donna RowenJennifer Roberts
May 28, 2009·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Dennis A RevickiDavid Cella
Jun 30, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nick KontodimopoulosDimitris Niakas
Feb 15, 2011·Journal of Neurosurgery·Asgeir S JakolaOle Solheim
Mar 22, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A Simon PickardDavid Cella
Dec 10, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Lisa Millgård SagbergOle Solheim
Feb 21, 2014·The New England Journal of Medicine·Mark R GilbertMinesh P Mehta
May 7, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Asgeir S JakolaOle Solheim
Jun 23, 2015·British Journal of Neurosurgery·Asgeir S JakolaOle Solheim
Oct 3, 2015·Journal of Neurosurgery·Lisa Millgård SagbergAsgeir S Jakola
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ethan BaschDeborah Schrag
Dec 9, 2016·Acta neurochirurgica·Asgeir Store JakolaLisa Millgård Sagberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.